Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging
September 15, 2024 06:05 ET
|
Precede Biosciences, Inc.
Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development Quantitative PSMA-PET...
Global Exosome Market Size, Forecast, Trials and Trends 2024: Exosome-Based Diagnostics and Therapeutics are Expanding, with 388 Clinical Trials Currently Underway
September 10, 2024 05:39 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Market: Size, Forecast, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com's offering. Exosomes are...
Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%
September 10, 2024 04:51 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Gene Editing Therapeutics Market" report has been added to ResearchAndMarkets.com's offering.The gene editing therapeutics market is estimated to be...
New Meta-Analysis Shows Treos Bio’s Promiscuous Epitopes in Their Off-The-Shelf Colorectal Cancer Immunotherapy Produce Stronger Immune Response than Traditional Epitopes
September 09, 2024 16:16 ET
|
Treos Bio Corp.
LONDON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Treos Bio announced the results of a meta-analysis from three clinical trials evaluating its investigational off-the-shelf immunotherapy, PolyPEPI1018, for...
Fimlab Is Adopting Proscia’s Software To Realize The Promise Of AI-Enabled Pathology
September 09, 2024 02:00 ET
|
Proscia
Fimlab Laboratories will use Proscia’s software platform to help its pathologists generate more precise results with artificial intelligence (AI).
Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients
September 04, 2024 08:00 ET
|
Proscia
Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data
gRNA Industry Research Report 2024: Size, Share, Trends, Opportunities, and Forecasts, 2019-2029F
September 03, 2024 09:39 ET
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "gRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Precision Medicine Market Report 2024: Comprehensive Data on Products, Technologies, Applications, End Users, Countries and Companies, 2024-2032, Featuring AstraZeneca, Bayer, bioMerieux, and More
September 02, 2024 09:41 ET
|
Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Market Report, Forecast by Product, Technology, Application, End User, Countries and Company Analysis, 2024-2032" report has been...
DNA Sequencing Global Strategic Research Report 2024: Growing Adoption of Sequencing Services in Clinical Workflows Propels Market Growth - Global Forecast to 2030
August 29, 2024 10:50 ET
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "DNA Sequencing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for DNA Sequencing is...
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
August 29, 2024 08:27 ET
|
Biognosys AG
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research